SUN PHARMA Surges by 6%; BSE HEALTHCARE Index Up 3.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 10th April, 2020 on account of Good Friday.

SUN PHARMA Surges by 6%; BSE HEALTHCARE Index Up 3.6%
Tue, 24 Mar 12:23 PM

SUN PHARMA share price has zoomed 6% and is presently trading at Rs 347.

Meanwhile, the BSE HEALTHCARE Index is at 11,583 (up 3.6%).

Among the top Gainers in the BSE HEALTHCARE Index today are SUN PHARMA (up 5.8%) and PROCTER & GAMBLE HEALTH (up 6.4%).

FDC LTD. (down 0.9%) and WOCKHARDT (down 1.0%) are among the top losers today.

Over the last one year, SUN PHARMA has moved down from Rs 464 to Rs 347, registering a loss of Rs 117 (down 26.2%).

On the other hand, the BSE HEALTHCARE has moved down from 14,114 to 11,583, loss of 2,531 points (down 19.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 87.4%), IPCA LABS (up 44.4%) and J.B.CHEMICALS (up 37.1%).

One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

What About the Benchmark Indices?

The BSE Sensex is at 27,463 (up 2.3%).

The top gainers among the BSE Sensex stocks today are HUL (up 8.5%), INFOSYS (up 7.5%) and SUN PHARMA (up 5.8%). Other gainers include NESTLE (up 5.7%) and BAJAJ FINANCE (up 5.6%). The most traded stocks in the BSE Sensex are SBI and ONGC.

In the meantime, NSE Nifty is at 8,037 (up 1.9%). The top gainers in the NSE Nifty include BRITANNIA (up 13.4%), ADANI PORTS & SEZ (up 10.6%) and CIPLA (up 8.1%). Other gainers include HUL (up 7.7%) and INFOSYS (up 7.2%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,809 to 27,463, registering a loss of 10,346 points (down 29.69%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 10 billion for the quarter ended December 2019, compared to a loss of Rs 15 billion a year ago. Net Sales rose 5.4% to Rs 81.5 billion during the period as against Rs 77.4 billion in October-December 2018.

For the year ended March 2019, SUN PHARMA reported 25.7% increase in net profit to Rs 44.2 billion compared to net profit of Rs 35.2 billion during FY18.

Revenue of the company grew 9.7% to Rs 291 billion during FY19.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 18.6x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Advertisement
Just Released! Our Special Report on the Coronavirus Crisis
The foundation for great wealth is laid in times of crisis... Here's how you could tap into the coronavirus crisis and potentially set yourself up for massive gains in the years to come. How to Trade the Coronavirus Crash - 1-Click FREE DOWNLOAD...

Equitymaster requests your view! Post a comment on "SUN PHARMA Surges by 6%; BSE HEALTHCARE Index Up 3.6%". Click here!

  

Stock Market Updates

Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark (Today's Market)

Apr 9, 2020 Closing

Indian share markets witnessed buying interest throughout the day and ended on a strong note.

VOLTAS Surges by 6%; BSE CAPITAL GOODS Index Up 1.6% (Today's Market)

Apr 9, 2020 03:33 PM

VOLTAS share price has surged by 6% and its current market price is Rs 515. The BSE CAPITAL GOODS is up by 1.6%. The top gainers in the BSE CAPITAL GOODS Index are VOLTAS (up 6.0%) and HEG (up 10.0%). The top losers are THERMAX (down 0.6%) and KALPATARU POWER (down 0.6%).

MARUTI SUZUKI Surges by 13%; BSE AUTO Index Up 10.2% (Today's Market)

Apr 9, 2020 03:33 PM

MARUTI SUZUKI share price has surged by 13% and its current market price is Rs 5,399. The BSE AUTO is up by 10.2%. The top gainers in the BSE AUTO Index are MARUTI SUZUKI (up 12.9%) and MRF LTD. (up 5.2%).

LUPIN Surges by 13%; BSE HEALTHCARE Index Up 3.4% (Today's Market)

Apr 9, 2020 03:33 PM

LUPIN share price has surged by 13% and its current market price is Rs 798. The BSE HEALTHCARE is up by 3.4%. The top gainers in the BSE HEALTHCARE Index are LUPIN (up 12.7%) and DIVIS LABORATORIES (up 6.2%). The top losers are J.B.CHEMICALS (down 0.2%) and PROCTER & GAMBLE HEALTH (down 1.2%).

TATA ELXSI Surges by 11%; BSE IT Index Up 1.6% (Today's Market)

Apr 9, 2020 03:29 PM

TATA ELXSI share price has surged by 11% and its current market price is Rs 712. The BSE IT is up by 1.6%. The top gainers in the BSE IT Index are TATA ELXSI (up 11.1%) and FIRSTSOURCE SOL. (up 12.2%). The top losers is TECH MAHINDRA (down 2.4%).

TITAN Surges by 12%; BSE 500 Index Up 3.8% (Today's Market)

Apr 9, 2020 03:29 PM

TITAN share price has surged by 12% and its current market price is Rs 1,040. The BSE 500 is up by 3.8%. The top gainers in the BSE 500 Index are TITAN (up 12.5%) and MARUTI SUZUKI (up 14.1%). The top losers are BLUE DART EXPRESS and UPL .

View More Indian Share Market News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Safe Stock to Lockdown Now(The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

How to Identify a Market Rebound(Fast Profits Daily)

Mar 27, 2020

This very useful indicator can spot a market bottom.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX


Apr 9, 2020 (Close)

OTHER USEFUL LINKS

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
  • Get Equitymaster Android App on Google Play
  • Get Equitymaster iOS App on App Store
FOLLOW

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.